Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
17 May 2022 | Story Lunga Luthuli | Photo Supplied
University of Limpopo visits UFS Protection Services
Staff from the University of the Free State Department of Protection Services pictured with the delegation from the University of Limpopo during their benchmarking visit.

The University of the Free State Department of Protection Services hosted a delegation from the University of Limpopo on Friday, 13 May 2022 as part of benchmarking best protection service practices. 

During the visit, discussions included the management of student protests, gender-based violence, fire emergency responses, and challenges experienced with the Campus Protection Society of Southern Africa.

The visit by the University of Limpopo follows similar benchmark visits by the Central University of Technology, Sol Plaatje University, and the University of Johannesburg.

Noko Masalesa, Senior Director: Protection Services, said: “The visit by the University of Limpopo was used to take them through our vision 2024, to show them some of the advanced CCTV cameras that the UFS has installed, the policies, and organisational structure. Part of that strategy is to enhance the university’s security technology in line with the best practices.”

Masalesa said: “The UFS has a good model to manage all the different functional areas of the Department of Protection Services, and most universities are impressed with the new CCTV cameras that we rolled out and the other advances made in the development of protection services over the past five years.”

To remain among the leaders in protection services within the higher education, the department also visited Stellenbosch University, the University of Cape Town, Cape Peninsula University of Technology, and the University of Nairobi and Kenyatta University – both in Kenya.

Mampuru Mampa, Director: Safety and Security at the University of Limpopo, said: “Like other institutions, the University of Limpopo is dealing with crimes affecting students on and off campus, as well as student protests. Fostering collaboration and benchmarking will assist our protection service departments to develop and implement a standardised approach to improve safety on our campuses.”

On lessons learnt during the benchmarking tour, Mampa said: “We have learnt about security system integration, investigation systems approach, off-campus security, and student protest management.”

Mampa believes “it is important for protection service departments across the higher education sector to develop standardised security measures to improve safety, and benchmarking assists in closing gaps in protection services”.

News Archive

Nuclear Medicine on the forefront of cancer research
2017-07-10

Description: Nuclear Medicine on the forefront of cancer research Tags: Nuclear Medicine, cancer research, Dr Je’nine Horn-Lodewyk’s, tumour detection method, cancer, Department of Nuclear Medicine 

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma.  The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept